Status:
COMPLETED
Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Conditions:
Vaccine Hesitancy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn compare the efficacy Chatbot messaging directed to parents of infants and children living in unstable urban housing (UUH) in Varansi, India. The main questi...
Detailed Description
Only 2/3 of Indian infants and children are fully immunized. In communities facing unstable urban housing (UUH) vaccination rates are even lower. COVID-19 introduced new challenges for community healt...
Eligibility Criteria
Inclusion
- Speak Hindi;
- Reside in selected UUH neighborhood of Varanasi, India;
- Identify as a caregiver of a young child (\<2) OR be at least 5 months pregnant and due to giver birth during the study period;
- Child is registered with local community health workers and included on patient rosters for vaccination clinics (also known as Village Health Sanitation and Nutrition Days (VHSNDs));
- Have regular access to a phone with WhatsApp.
Exclusion
- Only one caregiver is eligible per household
- Not meeting inclusion criteria.
Key Trial Info
Start Date :
September 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2024
Estimated Enrollment :
2058 Patients enrolled
Trial Details
Trial ID
NCT05994820
Start Date
September 26 2023
End Date
February 10 2024
Last Update
March 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
D-COR (Development Corner) Consulting
Dwārka, New Delhi, India, 110077